Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Jean Gautier Image

      Jean Gautier, PHD, Dr.Sc.

      Department of Epigenetics and Molecular Carcinogenesis, Division of Division of Discovery Science

      Present Title & Affiliation

      Primary Appointment

      Professor and Chair, Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      1988University of Toulouse, Toulouse, Occitania, FR, Developmental Biology, Dr. Sc, (Doctorat d’état es sciences)
      1983University of Toulouse, Toulouse, FR, Developmental Biology, PhD
      1978University of Toulouse, Toulouse, FR, Biology, MS

      Postgraduate Training

      1990-1992American Cancer Society Senior Postdoctoral Fellow, University of California San Francisco, California
      1988-1989Postdoctoral Fellow, University of Colorado Health Sciences Center, Colorado
      1987-1987Visiting Scientist, Indiana University, Bloomington, Indiana
      1983-1984Visiting Scientist, Free University of Brussels, Brussels

      Experience & Service

      Faculty Academic Appointments

      Adjunct Professor, Department of Genetics and Development, Columbia University, 2025 - 2026

      Professor, Department of Genetics and Development, Columbia University Medical Center, New York, New York, 2008 - 2025

      Associate Professor, Department of Genetics and Development, Columbia University Medical Center, New York City, New York, 2002 - 2008

      Assistant Professor, Department of Genetics and Development, Department of Dermatology, Columbia University Medical Center, New York, New York, 1995 - 2002

      Group Leader, Associate Member, Roche Institute of Molecular Biology, Nutley, New Jersey, 1993 - 1995

      Group Leader, Centre National de la Recherche Scientifique URA 671, Nice, 1992 - 1993

      Administrative Appointments/Responsibilities

      Director, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, 2022 - 2025

      Chair, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, 2020 - 2025

      Co-leader, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, 2019 - 2025

      Associate Director for Research, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, 2017 - 2019

      Leader, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, 2009 - 2019

      Other Professional Positions

      Permanent research scientist position as “Directeur de Recherches II”, Centre National de la Recherche Scientifique, 1992 - 2024

      Permanent research scientist position as “Chargé de Recherches I”, Centre National de la Recherche Scientifique, 1988 - 1992

      Permanent research scientist position as "Chargé de Recherches II, Centre National de la Recherche Scientifique, 1984 - 1988

      Intramural Institutional Committee Activities

      Member, Executive Committee of the Faculty Council of the School of Medicine, Columbia University Medical Center, 1998 - 2000

      Extramural Institutional Committee Activities

      HICCC representative, Basic Sciences Chair Meetings, Columbia University, 2020 - 2022

      Member, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, 2008 - 2025

      Member, Faculty search committee Institute for Cancer Genetics, Columbia University Medical Center, 2008 - 2025

      Member, Faculty Council of the School of Medicine, Columbia University Medical Center, 1996 - 2025

      Member, Executive Committee of the Department of Dermatology, Columbia University Medical Center, 1995 - 2002

      Member, Graduate Program in Biological Sciences, Columbia University

      Member, Molecular Pharmacology and Therapeutics Graduate Program, Columbia University

      Member, Medical Scientist Training Program, Columbia University

      Member, Cellular Molecular and Biomedical Studies Integrated Graduate Program, Columbia University

      Member, Genetics and Development Graduate Program, Columbia University

      Member, Biochemistry and Molecular Biophysics Graduate Program, Columbia University in the City of New York

      Honors & Awards

      2024 - PresentFellow of the American Association for the Advancement of Science (AAAS)
      2024HICCC Trainee Associate Member Mentor of the year
      2021The Levin Lecture, Dana Farber Cancer Institute
      2018 - 2024STARR Cancer Consortium, Scientific Review Board
      2016UICC Yamagiwa-Yoshida Memorial International Cancer Study Fellow
      2016Mayent – Rothschild Lecture, Curie Institute, Paris, France
      2015 - 2016Mayent – Rothschild Fellow, Curie Institute, France
      2015Outstanding Investigator Award, National Cancer Institute
      2002Dr. Harold and Golden Lamport Award for Excellence in Basic Science Research
      1997 - 2001Department of Defense – Breast Cancer Research Program Career Development Award
      1997 - 2001Irma T. Hirschl Scholar Award
      1996 - 1999Mallinckrodt Foundation Scholar
      1993 - 1995ATIPE, CNRS award, starting grant package (France)
      1990 - 1992Senior Post-doctoral Fellowship, American Cancer Society, University of California, San Francisco
      1989 - PresentEMBO Fellowship, Oxford University, Advisor: Prof. Paul Nurse (Nobel Laureate, Physiology and Medicine, 2001)
      1989Bronze medal CNRS, Developmental Biology, Life Sciences Section (France)
      1982IAESTE (International Association for Exchange of Student for Technical Experience) Fellow

      Professional Memberships

      American Association for the Advancement of Science

      American Society for Cell Biology

      American Association for Cancer Research

      Selected Presentations & Talks

      Local Presentations

      1. 2023. Invited Speaker. Philadelphia, Pennsylvania, US.
      2. 2015. Invited Speaker. Genome Integrity Discussion Group. New York, New York, US.
      3. 2013. Invited Speaker. Philadelphia, Pennsylvania, US.
      4. 2013. Invited Speaker. New York, New York, US.
      5. 2012. Invited Speaker. New York, New York, US.
      6. 2010. Invited Speaker. Department of Hematology/Oncology. Ithaca, New York, US.
      7. 2006. Invited Speaker. Department of Molecular Biology. New York, New York, US.
      8. 2004. Invited Speaker, US.
      9. 2003. Invited Speaker. Invited. Genome Stability Meeting, US.

      Regional Presentations

      1. 2006. Invited Speaker. Department of Molecular Biology. Ithaca, New York, US.
      2. 2006. Invited Speaker. Department of Therapeutic radiology. New Haven, Connecticut, US.
      3. 2005. Invited Speaker. Department of Radiation Oncology. Baltimore, Maryland, US.
      4. 2004. Invited Speaker. Invited, US.
      5. 2003. Invited Speaker. Invited. Philadelphia, Pennsylvania, US.

      National Presentations

      1. 2025. Invited Speaker. Cytoskeletal Structure, Dynamics, and Function, US.
      2. 2024. Invited Speaker. American Society for Cell Biology. San Diego, California, US.
      3. 2024. Invited Speaker. Genetic Recombination & Genome Rearrangements. Tucson, Arizona, US.
      4. 2023. Invited Speaker. Waltham, Massachusetts, US.
      5. 2023. Invited Speaker. Boston, Massachusetts, US.
      6. 2021. Invited Speaker. NCI Seminar Series, US.
      7. 2021. Invited Speaker. Seminars in Oncology, Levin Lecture,, US.
      8. 2019. Invited Speaker. NCI Workshop: Chromatin and Cell Fate Decision in Development, Aging and Cancer. Frederick, Maryland, US.
      9. 2019. Invited Speaker. NCI Workshop: Liquid phase separation as a cellular regulatory mechanism: State of the science and implications for cancer research. Frederick, Maryland, US.
      10. 2019. Invited Speaker. Inaugural Meeting of the National Cancer Institute’s Outstanding Investigators Award, US.
      11. 2018. Invited Speaker. San Diego, California, US.
      12. 2018. Invited Speaker. NCI Workshop: The Molecular Bases of the BRCA Phenotype in Human Cancer. Frederick, Maryland, US.
      13. 2017. Invited Speaker. Denver, Colorado, US.
      14. 2017. Invited Speaker. Recombination and Genetic Rearrangements. Steamboat Springs, Colorado, US.
      15. 2017. Invited Speaker. Dallas, Texas, US.
      16. 2016. Invited Speaker. Tucson, Arizona, US.
      17. 2016. Invited Speaker. Los Angeles, California, US.
      18. 2016. Invited Speaker. San Francisco, California, US.
      19. 2016. Invited Speaker. Invited. Houston, Texas, US.
      20. 2015. Invited Speaker. The Past and Future of Cellular, Molecular, and Systems Biology. Cambridge, Massachusetts, US.
      21. 2015. Invited Speaker. AACR: MYC: from biology to therapy. San Diego, California, US.
      22. 2015. Invited Speaker. Genetic Recombination & Genome. Steamboat Springs, Colorado, US.
      23. 2013. Invited Speaker. Boston, US.
      24. 2013. Invited Speaker. Mammalian DNA Repair. Ventura, California, US.
      25. 2013. Invited Speaker. 25rd Fanconi Anemia Symposium, US.
      26. 2013. Invited Speaker. Athens, Georgia, US.
      27. 2013. Invited Speaker. St Louis, Missouri, US.
      28. 2012. Invited Speaker. Radiation Oncology Grand Rounds. Detroit, Michigan, US.
      29. 2012. Invited Speaker. West Lafayette, Indiana, US.
      30. 2011. Invited Speaker. Keystone Symposium. Snowmass, Colorado, US.
      31. 2011. Invited Speaker. Rochester, Minnesota, US.
      32. 2011. Invited Speaker. John Anderson Symposium. Charlottesville, Virginia, US.
      33. 2011. Invited Speaker. Invited. Denver Cell Cycle Symposium. Denver, Colorado, US.
      34. 2011. Invited Speaker. Invited. Houston, Texas, US.
      35. 2011. Invited Speaker. Genetic Recombination and Genome Rearrangements. Steamboat Springs, Colorado, US.
      36. 2011. Invited Speaker. DNA Replication and Recombination. Taos, New Mexico, US.
      37. 2010. Invited Speaker. 22rd Fanconi Anemia Scientific Symposium. Minneapolis, Minnesota, US.
      38. 2009. Invited Speaker. Albuquerque, New Mexico, US.
      39. 2009. Invited Speaker. 21st Fanconi Anemia Scientific Symposium. Portland, US.
      40. 2009. Invited Speaker. Department of Cell Biology. Saint Louis, Missouri, US.
      41. 2009. Invited Speaker. Tampa, Florida, US.
      42. 2009. Invited Speaker. Genetic Recombination and Genome Rearrangements. Snowmass, Colorado, US.
      43. 2009. Invited Speaker. Cell Growth and Proliferation. Waterville, Maine, US.
      44. 2007. Invited Speaker. Genetic Recombination and Genome Rearrangements. Snowmass, Colorado, US.
      45. 2007. Invited Speaker. Tampa, Florida, US.
      46. 2006. Invited Speaker. Department of Radiation Biology. New York, New York, US.
      47. 2006. Invited Speaker. Department of Biology. Nashville, Tennessee, US.
      48. 2005. Invited Speaker. Department of Molecular Genetics. Austin, Texas, US.
      49. 2005. Invited Speaker. Department of Pharmacology. Madison, Wisconsin, US.
      50. 2005. Session Chair. DNA Replication and Recombination. Taos, New Mexico, US.
      51. 2005. Invited Speaker. Department of Molecular Biology. Dallas, Texas, US.
      52. 2004. Session Chair. Panelist. DNA Replication and Genome Stability, US.
      53. 2004. Invited Speaker. Invited. Department of Molecular Medicine, US.
      54. 2004. Invited Speaker. Invited, US.
      55. 2003. Invited Speaker. Genetic Recombination and Genome Rearrangements. Snowmass, Colorado, US.
      56. 2003. Invited Speaker. Mammalian DNA Repair. Ventura, California, US.
      57. 2003. Invited Speaker. Second Messengers and Protein Phosphorylation, New Hampshire, US.
      58. 2003. Invited Speaker. Invited. Houston, Texas, US.
      59. 2003. Departmental Seminar. Invited, US.
      60. 2003. Invited Speaker. Invited. Department of Cell Biology, US.
      61. 2003. Invited Speaker. Invited. DNA Replication and Genome Stability. La Jolla, California, US.

      International Presentations

      1. 2024. Session Chair. DNA repair pathways as targets for cancer therapy, MT.
      2. 2024. Invited Speaker. Nuclear Actin Symposium. Abu-Dhabi, AE.
      3. 2022. Invited Speaker. Nuclear Actin Symposium. Szeged, HU.
      4. 2020. Invited Speaker. First CABIMER International Workshop: “Trends in Genome Integrity & Chromosome Dynamics”. Sevilleja de la Jara, ES.
      5. 2019. Invited Speaker. Fusion Conference: Spatial genome organization, BS.
      6. 2017. Invited Speaker. Ataxia-Telangiectasia Workshop. Milan, IT.
      7. 2017. Invited Speaker. Fusion conference: Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference. Cancun, MX.
      8. 2017. Invited Speaker. Chromatin organization. Whistler, CA.
      9. 2016. Invited Speaker. Orsay, FR.
      10. 2016. Invited Speaker. DINGO meeting: replication stress, genetic instability and cancer. Paris, FR.
      11. 2016. Invited Speaker. Paris, FR.
      12. 2016. Invited Speaker. Institute of Integrative Biology of the Cell. Gif-sur-Yvette, FR.
      13. 2016. Invited Speaker, GB.
      14. 2016. Invited Speaker. Transcription-Replication Crosstalk and Genome Instability. Roscoff, FR.
      15. 2016. Invited Speaker. IFOM. Milan, IT.
      16. 2015. Invited Speaker. Curie Institute, Paris, Mayent-Rothschild Seminar. Paris, FR.
      17. 2015. Invited Speaker. IGBMC. Strasbourg, FR.
      18. 2015. Invited Speaker. Genome Instability and Cancer: new ideas. Paris, FR.
      19. 2014. Invited Speaker. ABCAM Meeting, KN.
      20. 2014. Invited Speaker. Peking, CN.
      21. 2014. Invited Speaker. Gordon Conference:Mutagenesis. Gerona, PH.
      22. 2013. Invited Speaker. FEBS Workshop, NER and ICL Repair, SK.
      23. 2013. Invited Speaker. Brno, CZ.
      24. 2012. Invited Speaker. 14th AT Workshop. Delhi, IN.
      25. 2012. Invited Speaker. Recombination Mechanism and Genome Instability. Jerez de la Frontera, ES.
      26. 2011. Invited Speaker. 23rd Fanconi Anemia Symposium. Barcelona, ES.
      27. 2010. Invited Speaker. International Ataxia-Telangieactasia Workshop. Los Angeles, US.
      28. 2010. Invited Speaker, GB.
      29. 2010. Invited Speaker. International Xenopus Conference. Lake Louise, CA.
      30. 2008. Invited Speaker. IRCM. Montreal, CA.
      31. 2008. Invited Speaker. International Ataxia-Telangiectasia Workshop. Kyoto, JP.
      32. 2007. Invited Speaker. Cancer Models and Mechanisms. Les Diablerets, CH.
      33. 2007. Invited Speaker. Cancer Colloquium on Origins of Cancer. St Andrews.
      34. 2007. Invited Speaker. 2nd International Gene Center-SFB 646 Symposium. Munich, DE.
      35. 2007. Invited Speaker. CNIO Cancer Conference: Links between cancer, replication stress and genomic integrity. Madrid, ES.
      36. 2007. Invited Speaker. VI International Symposium on Cell Death and Aging. Paris, FR.
      37. 2007. Invited Speaker - Plenary Lecture. Giens, FR.
      38. 2006. Invited Speaker. International Ataxia-Telangiectasia Workshop. Banff, CA.
      39. 2005. Session Chair. Benzon Symposium on Genome Stability. Copenhagen, DK.
      40. 2005. Session Chair. International Ataxia-Telangiectasia Workshop. Lago Maggiore, IT.
      41. 2004. Invited Speaker. Genome Stability. Roscoff, FR.
      42. 2004. Invited Speaker. Recombination, Replication and Genome Stability. Seilhac, FR.
      43. 2004. Invited Speaker. IFOM Conference. Milan, IT.
      44. 2003. Invited Speaker. Invited. Cell Cycle. Roscoff, FR.
      45. 2003. Invited Speaker. Invited. 8th International Ataxia-Telangiectasia Workshop. Frazier Island, AU.
      46. 2003. Invited Speaker. Invited. Symposium on Genome Stability. Kyoto, JP.
      47. 2003. Keyote Speaker. Invited. Australian Cell Cycle Conference. Melbourne, AU.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2032
      Title:Transcription-driven genome instability, DNA repair and cancer
      Funding Source:NIH
      Role:PI
      ID:R01CA304149-01A1
      Date: 2025 - 2030
      Title:Spatial Dynamics of Transcription-Driven Genome Instability in Cancer Development and Therapy
      Funding Source:CPRIT
      Role:PI
      ID:RR250073
      Date: 2025 - 2029
      Title:Transcription-Driven Genome Instability, DNA repair and cancer
      Funding Source:NIH/NCI
      Role:Co-PI
      ID:R01CA304149
      Date: 2024 - 2029
      Title:Maintenance of genome stability in 3D
      Funding Source:NIH/NCI
      Role:PI
      ID:4R01CA287287-03 (Columbia through 6/1/25; UTMDACC from 6/2/25 - Current)
      Date: 2016 - 2018
      Title:Cancer Biology Training Grant
      Funding Source:NIH/NCI
      Role:Contact PI/Project Leader
      ID:T32CA009503
      Date: 2015 - 2023
      Title:DNA Repair and Genomic Instability in Cancer Development and Therapy
      Funding Source:NIH/NCI
      Role:PI
      ID:R35CA197606
      Date: 2014 - 2025
      Title:DNA double strand break repair, chromosome translocations and cancer
      Funding Source:NIH/NCI
      Role:PI
      ID:P01CA174653
      Date: 2012 - 2016
      Title:Studies of DNA interstrand crosslink repair to improve crosslinking drug therapie (Rolled into R35CA197606)
      Funding Source:NIH/NCI
      Role:PI
      ID:R01CA167826 (Rolled in to R35CA197606)
      Date: 2011 - 2012
      Title:Evaluating Interstrand Crosslink (ICL) Repair in Triple-Negative Breast Cancers to Guide Chemotheraphy
      Funding Source:Department of Defense
      Role:PI
      ID:W81XWH-11-1-0265-Proposal Number: BC103035
      Date: 2009 - 2011
      Title:Regulation of the DNA damage response by the MRN-ATM pathway
      Funding Source:NIH/NCI
      Role:PI
      ID:R01CA092245-08S1
      Date: 2009 - 2010
      Title:Regulation of DNA Replication by MCM Proteins
      Funding Source:NIH/NCI
      Role:PI
      ID:R01GM077495-02S1
      Date: 2008 - 2025
      Title:Cancer Center Support Grant
      Funding Source:NIH/NCI
      Role:Co Leader
      ID:P30-CA013696
      Date: 2008 - 2011
      Title:Coordination of BRCA1/BARD1- and MRE11/RAD50/NBS1-dependent DNA transactions in breast tumor suppression
      Funding Source:Department of Defense/BCRP
      Role:PI
      ID:W81XWH-08-1-0426; BC073889
      Date: 2008 - 2013
      Title:Regulation of DNA Replication by MCM Proteins
      Funding Source:NIH/NIGMS
      Role:PI
      ID:R01GM077495
      Date: 2005 - 2006
      Title:Tumor Suppression by BRCA1: A Critical Role at DNA Replication Forks?
      Funding Source:Department of Defense
      Role:PI
      ID:W81XWH-05-1-0494; BC045534
      Date: 2002 - 2007
      Title:Probing the DNA Damage Response In Vitro
      Funding Source:NIH/NCI
      Role:PI
      ID:R01CA095866
      Date: 2002 - 2016
      Title:Regulation of the DNA damage response by ATM-MRN pathway
      Funding Source:NIH/NCI
      Role:PI
      ID:R01CA092245 (Rolled into R35CA197606)
      Date: 1999 - 2003
      Title:Cell Cycle Control by the Camp PKA Signal Transduction
      Funding Source:NIH/NIGMS
      Role:PI
      ID:R01GM056781
      Date: 1997 - 2001
      Title:The Functional Role of the Ataxia-Telangiectasia Gene
      Funding Source:Department of Defense
      Role:PI
      ID:DAMD17-97-1-7071; BC961806
      Date: 1997 - 2000
      Title:Grant RPG-99-040-01-CCG
      Funding Source:American Cancer Society
      Role:PI
      ID:RPG-99-040-01-CCG

      Selected Publications

      Peer-Reviewed Articles

      1. Liebau RC, Waters C, Ahmed A, Soni RK, Gautier J. UVSSA facilitates transcription-coupled repair of DNA interstrand crosslinks. DNA Repair (Amst) 143:103771, 2024. e-Pub 2024. PMID: 39383571.
      2. Liebau RC, Waters C, Ahmed A, Soni RK, Gautier J. Transcription-Coupled Repair of DNA Interstrand Crosslinks by UVSSA. bioRxiv, 2024. e-Pub 2024. PMID: 37214867.
      3. Min, J, Zhao, J, Zagelbaum, JA, Lee, J, Takahashi, S, Cummings, P, Schooley, A, Dekker, J, Gottesman, M, Rabadan, R, Gautier, J. Mechanisms of insertions at a DNA double-strand break. Molecular cell 83(14):2434-2448.e7, 2023. e-Pub 2023. PMID: 37402370.
      4. Zagelbaum, JA, Gautier, J. Double-strand break repair and mis-repair in 3D. DNA Repair 121, 2023. e-Pub 2023. PMID: 36436496.
      5. Zagelbaum, JA, Schooley, A, Zhao, J, Schrank, B, Callen, E, Zha, S, Gottesman, M, Nussenzweig, A, Rabadan, R, Dekker, J, Gautier, J. Multiscale reorganization of the genome following DNA damage facilitates chromosome translocations via nuclear actin polymerization. Nature Structural and Molecular Biology 30(1):99-106, 2023. e-Pub 2023. PMID: 36564591.
      6. Alvarez S, da Silva Almeida AC, Albero R, Biswas M, Barreto-Galvez A, Gunning TS, Shaikh A, Aparicio T, Wendorff A, Piovan E, Van Vlierberghe P, Gygi S, Gautier J, Madireddy A, A Ferrando A. Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics, and DNA repair. Blood 139(23):3418-3429, 2022. e-Pub 2022. PMID: 35338774.
      7. Wang XS, Menolfi D, Wu-Baer F, Fangazio M, Meyer SN, Shao Z, Wang Y, Zhu Y, Lee BJ, Estes VM, Cupo OM, Gautier J, Pasqualucci L, Dalla-Favera R, Baer R, Zha S. DNA damage-induced phosphorylation of CtIP at a conserved ATM/ATR site T855 promotes lymphomagenesis in mice. Proc Natl Acad Sci U S A 118(38), 2021. e-Pub 2021. PMID: 34521752.
      8. Prakash R, Sandoval T, Morati F, Zagelbaum JA, Lim PX, White T, Taylor B, Wang R, Desclos ECB, Sullivan MR, Rein HL, Bernstein KA, Krawczyk PM, Gautier J, Modesti M, Vanoli F, Jasin M. Distinct pathways of homologous recombination controlled by the SWS1-SWSAP1-SPIDR complex. Nat Commun 12(1):4255, 2021. e-Pub 2021. PMID: 34253720.
      9. Tao Y, Aparicio T, Li M, Leong KW, Zha S, Gautier J. Inhibition of DNA replication initiation by silver nanoclusters. Nucleic Acids Res 49(9):5074-5083, 2021. e-Pub 2021. PMID: 33905520.
      10. Sato M, Liebau RC, Liu Z, Liu L, Rabadan R, Gautier J. The UVSSA complex alleviates MYC-driven transcription stress. J Cell Biol 220(2), 2021. e-Pub 2021. PMID: 33404608.
      11. Wang XS, Zhao J, Wu-Baer F, Shao Z, Lee BJ, Cupo OM, Rabadan R, Gautier J, Baer R, Zha S. CtIP-mediated DNA resection is dispensable for IgH class switch recombination by alternative end-joining. Proc Natl Acad Sci U S A 117(41):25700-25711, 2020. e-Pub 2020. PMID: 32989150.
      12. Tao Y, Li M, Liu X, Leong KW, Gautier J, Zha S. Dual-Color Plasmonic Nanosensor for Radiation Dosimetry. ACS Appl Mater Interfaces 12(20):22499-22506, 2020. e-Pub 2020. PMID: 32337977.
      13. Liu X, Wang XS, Lee BJ, Wu-Baer FK, Lin X, Shao Z, Estes VM, Gautier J, Baer R, Zha S. CtIP is essential for early B cell proliferation and development in mice. J Exp Med 216(7):1648-1663, 2019. e-Pub 2019. PMID: 31097467.
      14. Schrank BR, Aparicio T, Li Y, Chang W, Chait BT, Gundersen GG, Gottesman ME, Gautier J. Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559(7712):61-66, 2018. e-Pub 2018. PMID: 29925947.
      15. Kato N, Kawasoe Y, Williams H, Coates E, Roy U, Shi Y, Beese LS, Scharer OD, Yan H, Gottesman ME, Takahashi TS, Gautier J. Sensing and Processing of DNA Interstrand Crosslinks by the Mismatch Repair Pathway. Cell Rep 21(5):1375-1385, 2017. e-Pub 2017. PMID: 29091773.
      16. Aparicio T, Baer R, Gottesman M, Gautier J. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts. J Cell Biol 212(4):399-408, 2016. e-Pub 2016. PMID: 26880199.
      17. Sato M, Rodriguez-Barrueco R, Yu J, Do C, Silva JM, Gautier J. MYC is a critical target of FBXW7. Oncotarget 6(5):3292-305, 2015. e-Pub 2015. PMID: 25669969.
      18. Srinivasan SV, Dominguez-Sola D, Wang LC, Hyrien O, Gautier J. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep 3(5):1629-39, 2013. e-Pub 2013. PMID: 23643534.
      19. Rozier L, Guo Y, Peterson S, Sato M, Baer R, Gautier J, Mao Y. The MRN-CtIP pathway is required for metaphase chromosome alignment. Mol Cell 49(6):1097-107, 2013. e-Pub 2013. PMID: 23434370.
      20. Peterson SE, Li Y, Wu-Baer F, Chait BT, Baer R, Yan H, Gottesman ME, Gautier J. Activation of DSB processing requires phosphorylation of CtIP by ATR. Mol Cell 49(4):657-67, 2013. e-Pub 2013. PMID: 23273981.
      21. Williams HL, Gottesman ME, Gautier J. Replication-independent repair of DNA interstrand crosslinks. Mol Cell 47(1):140-7, 2012. e-Pub 2012. PMID: 22658724.
      22. Peterson SE, Li Y, Chait BT, Gottesman ME, Baer R, Gautier J. Cdk1 uncouples CtIP-dependent resection and Rad51 filament formation during M-phase double-strand break repair. J Cell Biol 194(5):705-20, 2011. e-Pub 2011. PMID: 21893598.
      23. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, Wang K, Sumazin P, Kustagi M, Bisikirska BC, Basso K, Beltrao P, Krogan N, Gautier J, Dalla-Favera R, Califano A. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6:377, 2010. e-Pub 2010. PMID: 20531406.
      24. Kurth I, Gautier J. Origin-dependent initiation of DNA replication within telomeric sequences. Nucleic Acids Res 38(2):467-76, 2010. e-Pub 2010. PMID: 19906732.
      25. Di Virgilio M, Ying CY, Gautier J. PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin. DNA Repair (Amst) 8(11):1311-20, 2009. e-Pub 2009. PMID: 19709933.
      26. Ben-Yehoyada M, Wang LC, Kozekov ID, Rizzo CJ, Gottesman ME, Gautier J. Checkpoint signaling from a single DNA interstrand crosslink. Mol Cell 35(5):704-15, 2009. e-Pub 2009. PMID: 19748363.
      27. Roques C, Coulombe Y, Delannoy M, Vignard J, Grossi S, Brodeur I, Rodrigue A, Gautier J, Stasiak AZ, Stasiak A, Constantinou A, Masson JY. MRE11-RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair. EMBO J 28(16):2400-13, 2009. e-Pub 2009. PMID: 19609304.
      28. Rass E, Grabarz A, Plo I, Gautier J, Bertrand P, Lopez BS. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat Struct Mol Biol 16(8):819-24, 2009. e-Pub 2009. PMID: 19633668.
      29. Wang LC, Stone S, Hoatlin ME, Gautier J. Fanconi anemia proteins stabilize replication forks. DNA Repair (Amst) 7(12):1973-81, 2008. e-Pub 2008. PMID: 18786657.
      30. Richard DJ, Bolderson E, Cubeddu L, Wadsworth RI, Savage K, Sharma GG, Nicolette ML, Tsvetanov S, McIlwraith MJ, Pandita RK, Takeda S, Hay RT, Gautier J, West SC, Paull TT, Pandita TK, White MF, Khanna KK. Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453(7195):677-81, 2008. e-Pub 2008. PMID: 18449195.
      31. Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, Kopelovich L, Jasin M, Baer R, Paull TT, Gautier J. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 4(2):119-25, 2008. e-Pub 2008. PMID: 18176557.
      32. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R. Non-transcriptional control of DNA replication by c-Myc. Nature 448(7152):445-51, 2007. e-Pub 2007. PMID: 17597761.
      33. Bhaskara V, Dupre A, Lengsfeld B, Hopkins BB, Chan A, Lee JH, Zhang X, Gautier J, Zakian V, Paull TT. Rad50 adenylate kinase activity regulates DNA tethering by Mre11/Rad50 complexes. Mol Cell 25(5):647-61, 2007. e-Pub 2007. PMID: 17349953.
      34. Dupre A, Boyer-Chatenet L, Gautier J. Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex. Nat Struct Mol Biol 13(5):451-7, 2006. e-Pub 2006. PMID: 16622404.
      35. Sobeck A, Stone S, Costanzo V, de Graaf B, Reuter T, de Winter J, Wallisch M, Akkari Y, Olson S, Wang W, Joenje H, Christian JL, Lupardus PJ, Cimprich KA, Gautier J, Hoatlin ME. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol Cell Biol 26(2):425-37, 2006. e-Pub 2006. PMID: 16382135.
      36. Ying CY, Gautier J. The ATPase activity of MCM2-7 is dispensable for pre-RC assembly but is required for DNA unwinding. EMBO J 24(24):4334-44, 2005. e-Pub 2005. PMID: 16369567.
      37. Di Virgilio M, Gautier J. Repair of double-strand breaks by nonhomologous end joining in the absence of Mre11. J Cell Biol 171(5):765-71, 2005. e-Pub 2005. PMID: 16330708.
      38. Eyers PA, Liu J, Hayashi NR, Lewellyn AL, Gautier J, Maller JL. Regulation of the G(2)/M transition in Xenopus oocytes by the cAMP-dependent protein kinase. J Biol Chem 280(26):24339-46, 2005. e-Pub 2005. PMID: 15860459.
      39. Yeo W, Gautier J. XNGNR1-dependent neurogenesis mediates early neural cell death. Mech Dev 122(5):635-44, 2005. e-Pub 2005. PMID: 15817221.
      40. Shechter D, Gautier J. ATM and ATR check in on origins: a dynamic model for origin selection and activation. Cell Cycle 4(2):235-8, 2005. e-Pub 2005. PMID: 15655372.
      41. Gautier J, Delmotte F, Roulliay M, Bridou F, Ravet MF, Jerome A. Study of normal incidence of three-component multilayer mirrors in the range 20-40 nm. Appl Opt 44(3):384-90, 2005. e-Pub 2005. PMID: 15717828.
      42. Giordano-Coltart J, Ying CY, Gautier J, Hurwitz J. Studies of the properties of human origin recognition complex and its Walker A motif mutants. Proc Natl Acad Sci U S A 102(1):69-74, 2005. e-Pub 2005. PMID: 15618391.
      43. Shechter D, Ying CY, Gautier J. DNA unwinding is an Mcm complex-dependent and ATP hydrolysis-dependent process. J Biol Chem 279(44):45586-93, 2004. e-Pub 2004. PMID: 15326181.
      44. O'Shaughnessy RF, Yeo W, Gautier J, Jahoda CA, Christiano AM. The WNT signalling modulator, Wise, is expressed in an interaction-dependent manner during hair-follicle cycling. J Invest Dermatol 123(4):613-21, 2004. e-Pub 2004. PMID: 15373764.
      45. Shechter D, Gautier J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates. Proc Natl Acad Sci U S A 101(30):10845-6, 2004. e-Pub 2004. PMID: 15263078.
      46. Shechter D, Costanzo V, Gautier J. ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol 6(7):648-55, 2004. e-Pub 2004. PMID: 15220931.
      47. Costanzo V, Paull T, Gottesman M, Gautier J. Mre11 assembles linear DNA fragments into DNA damage signaling complexes. PLoS Biol 2(5):E110, 2004. e-Pub 2004. PMID: 15138496.
      48. Yeo W, Gautier J. A role for programmed cell death during early neurogenesis in xenopus. Dev Biol 260(1):31-45, 2003. e-Pub 2003. PMID: 12885553.
      49. Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, Gautier J. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11(1):203-13, 2003. e-Pub 2003. PMID: 12535533.
      50. Kim AL, Gautier J, Bickers DR, Athar M. Reduced cyclin D1 ubiquitination in UVB-induced murine squamous cell carcinomas. Biochem Biophys Res Commun 298(3):377-82, 2002. e-Pub 2002. PMID: 12413951.
      51. Kim AL, Athar M, Bickers DR, Gautier J. Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53. J Invest Dermatol 118(5):818-24, 2002. e-Pub 2002. PMID: 11982759.
      52. Kim AL, Athar M, Bickers DR, Gautier J. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem Photobiol 75(1):58-67, 2002. e-Pub 2002. PMID: 11837328.
      53. D'Angiolella V, Costanzo V, Gottesman ME, Avvedimento EV, Gautier J, Grieco D. Role for cyclin-dependent kinase 2 in mitosis exit. Curr Biol 11(15):1221-6, 2001. e-Pub 2001. PMID: 11516956.
      54. Costanzo V, Robertson K, Bibikova M, Kim E, Grieco D, Gottesman M, Carroll D, Gautier J. Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol Cell 8(1):137-47, 2001. e-Pub 2001. PMID: 11511367.
      55. Athar M, Kim AL, Ahmad N, Mukhtar H, Gautier J, Bickers DR. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53. Biochem Biophys Res Commun 277(1):107-11, 2000. e-Pub 2000. PMID: 11027648.
      56. Costanzo V, Robertson K, Ying CY, Kim E, Avvedimento E, Gottesman M, Grieco D, Gautier J. Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol Cell 6(3):649-59, 2000. e-Pub 2000. PMID: 11030344.
      57. Shechter DF, Ying CY, Gautier J. The intrinsic DNA helicase activity of Methanobacterium thermoautotrophicum delta H minichromosome maintenance protein. J Biol Chem 275(20):15049-59, 2000. e-Pub 2000. PMID: 10747908.
      58. Romanowski P, Marr J, Madine MA, Rowles A, Blow JJ, Gautier J, Laskey RA. Interaction of Xenopus Cdc2 x cyclin A1 with the origin recognition complex. J Biol Chem 275(6):4239-43, 2000. e-Pub 2000. PMID: 10660590.
      59. Bao J, Talmage DA, Role LW, Gautier J. Regulation of neurogenesis by interactions between HEN1 and neuronal LMO proteins. Development 127(2):425-35, 2000. e-Pub 2000. PMID: 10603358.
      60. Robertson K, Hensey C, Gautier J. Isolation and characterization of Xenopus ATM (X-ATM): expression, localization, and complex formation during oogenesis and early development. Oncogene 18(50):7070-9, 1999. e-Pub 1999. PMID: 10597308.
      61. Costanzo V, Avvedimento EV, Gottesman ME, Gautier J, Grieco D. Protein kinase A is required for chromosomal DNA replication. Curr Biol 9(16):903-6, 1999. e-Pub 1999. PMID: 10469595.
      62. Roberts BT, Ying CY, Gautier J, Maller JL. DNA replication in vertebrates requires a homolog of the Cdc7 protein kinase. Proc Natl Acad Sci U S A 96(6):2800-4, 1999. e-Pub 1999. PMID: 10077591.
      63. Hensey C, Gautier J. Developmental regulation of induced and programmed cell death in Xenopus embryos. Ann N Y Acad Sci 887:105-19, 1999. e-Pub 1999. PMID: 10668468.
      64. Hensey C, Gautier J. Programmed cell death during Xenopus development: a spatio-temporal analysis. Dev Biol 203(1):36-48, 1998. e-Pub 1998. PMID: 9806771.
      65. Sible JC, Erikson E, Hendrickson M, Maller JL, Gautier J. Developmental regulation of MCM replication factors in Xenopus laevis. Curr Biol 8(6):347-50, 1998. e-Pub 1998. PMID: 9512418.
      66. Hensey C, Gautier J. A developmental timer that regulates apoptosis at the onset of gastrulation. Mech Dev 69(1-2):183-95, 1997. e-Pub 1997. PMID: 9486540.
      67. Hendrickson M, Madine M, Dalton S, Gautier J. Phosphorylation of MCM4 by cdc2 protein kinase inhibits the activity of the minichromosome maintenance complex. Proc Natl Acad Sci U S A 93(22):12223-8, 1996. e-Pub 1996. PMID: 8901561.
      68. Gabrielli BG, Roy LM, Gautier J, Philippe M, Maller JL. A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2. J Biol Chem 267(3):1969-75, 1992. e-Pub 1992. PMID: 1309805.
      69. Gautier J, Maller JL. Cyclin B in Xenopus oocytes: implications for the mechanism of pre-MPF activation. EMBO J 10(1):177-82, 1991. e-Pub 1991. PMID: 1824935.
      70. Roy LM, Singh B, Gautier J, Arlinghaus RB, Nordeen SK, Maller JL. The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Cell 61(5):825-31, 1990. e-Pub 1990. PMID: 2140529.
      71. Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL. Cyclin is a component of maturation-promoting factor from Xenopus. Cell 60(3):487-94, 1990. e-Pub 1990. PMID: 1967981.
      72. Langan TA, Gautier J, Lohka M, Hollingsworth R, Moreno S, Nurse P, Maller J, Sclafani RA. Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells. Mol Cell Biol 9(9):3860-8, 1989. e-Pub 1989. PMID: 2550805.
      73. Gautier J, Matsukawa T, Nurse P, Maller J. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle. Nature 339(6226):626-9, 1989. e-Pub 1989. PMID: 2543932.
      74. Gautier J, Norbury C, Lohka M, Nurse P, Maller J. Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+. Cell 54(3):433-9, 1988. e-Pub 1988. PMID: 3293803.
      75. Gautier J, Tencer R. Involvement of the cytoskeleton in early grey crescent formation in axolotl oocytes. Rouxs Arch Dev Biol 196(5):316-320, 1987. e-Pub 1987. PMID: 28305553.
      76. Gautier J, Tencer R. Changes in patterns of protein synthesis in axolotl oocytes during progesterone-induced maturation. J Embryol Exp Morphol 92:103-13, 1986. e-Pub 1986. PMID: 3723056.
      77. Gautier J, Beetschen JC. Inhibition of protein synthesis elicits early grey crescent formation in the axolotl oocyte. Wilehm Roux Arch Dev Biol 192(3-4):196-199, 1983. e-Pub 1983. PMID: 28305127.
      78. Gautier J, Bird DM, Ng Kwai Hang KF. Plasma protein patterns in captive American kestrels. Comp Biochem Physiol A Comp Physiol 75(2):163-6, 1983. e-Pub 1983. PMID: 6135535.

      Review Articles

      1. Ahmed, A, Kato, N, Gautier, J. Replication-Independent ICL Repair. Journal of Molecular Biology 436(13), 2024. e-Pub 2024. PMID: 38763228.
      2. Aparicio T, Baer R, Gautier J. DNA double-strand break repair pathway choice and cancer. DNA Repair (Amst) 19:169-75, 2014. e-Pub 2014. PMID: 24746645.
      3. Costanzo V, Gautier J. Single-strand DNA gaps trigger an ATR- and Cdc7-dependent checkpoint. Cell Cycle 2(1):17, 2003. e-Pub 2003. PMID: 12695677.
      4. Greenwood J, Costanzo V, Robertson K, Hensey C, Gautier J. Responses to DNA damage in Xenopus: cell death or cell cycle arrest. Novartis Found Symp 237:221-30; discussion 230-4, 2001. e-Pub 2001. PMID: 11444046.
      5. Maller Jl, Gautier J, Langan TA, Lohka MJ, Shenoy S, Shalloway D, Nurse P. Maturation-promoting factor and the regulation of the cell cycle. J Cell Sci Suppl 12:53-63, 1989. e-Pub 1989. PMID: 2699738.

      Other Articles

      1. Gautier J, Ahmed A, Kato N Replication-independent ICL repair: from chemotherapy to cell homeostasis 436(13):168618, 2024. PMID: 38763228.
      2. Dominguez-Sola, D, Ying, CY, Grandori, C, Ruggiero, L, Chen, B, Li, M, Galloway, D, Gu, W, Gautier, J, Dalla-Favera, R Author Correction. Nature 619(7969):E39, 2023. PMID: 37386298.
      3. Gautier J, Schrank B Assembling Nuclear Domains: Lessons from DNA repair. Jurnal Cell Biology 218(8)(5):2444-2455, 2019. PMID: 31324649.
      4. Gautier J, Dominguez-Sola D MYC and the control of DNA Replication. Cold Spring Harb Perspect Med 6(4):a014423, 2014. PMID: 24890833.
      5. Gautier J, Symington LS Double strand breaks end resection and repair pathway choice. Annual Review of Genetics 45:247-271, 2011. PMID: 21910633.
      6. Gautier J, Wang, LC The Fanconi anemia pathway and ICL repair: implications for cancer therapy. Critical Reviews In Biochemistry & Molecular Biology 45(5):424-39, 2010. PMID: 20807115.
      7. Gautier J, Peterson S, Wang L, Robertson K, Torchon G, Ouerfelli O Corrected structure of mirin, a small molecule inhibitor of the Mre11-Rad50-Nbs1 complex. Nature Chemical Biology 5:130, 2009.
      8. Gautier J, Shecter D MCM proteins and checkpoint kinases get together at the fork. Proceeding National of the Academy Sciences 101:10845-6, 2004.
      9. Gautier J The role of the germinal vesicle for maturation-promoting factor activity in the Axolotl oocyte. Developmental Biology 123:483-486, 1987.
      10. Gautier J, Beetschen JC Heat-shock induced grey crescent in Axolotl oocytes and eggs: the role of gravity. Development 100:599-609, 1987.
      11. Gautier J, Bird D.M., Monpetit V Embryonic growth of american kestrels. The Auk 101:392-396, 1984.
      12. Gautier J, Beetschen JC La formation du croissant gris induite dans l'ovocyte d'axolotl en cours de maturation, depends de facteurs d'origine nucleaire. Comptes Rendus Academie Sciences Paris Ser III 296:815-818, 1983.
      13. Gautier J, Williams H, Gottesman M.E. The differences between ICL repair during and outside of S phase. Trends in Biochemical Sciences(38):386-393. PMID: 23830640.
      14. Gautier J, Aparicio T BRCA1-CtIP interaction in the repair of DNA double-strand breaks. Molecular Cell Oncology. PMID: 27652321.
      15. Gautier J. PMID: 1913817.
      16. Gautier J, Min J Chromatin compartments at DNA double-stranded breaks. Cell Research(34(5)):337-338. PMID: 38097773.

      Abstracts

      1. Wolf MA, Gautier J. Physiopathologie et traitement curatif des dyskinesies tardives. Encephale 13(5):301-8, 1987. e-Pub 1987. PMID: 2892663.
      2. Gautier J, Beetschen JC. La formation du croissant gris, induite dans l'ovocyte d'axolotl en cours de maturation, depend de facteurs d'origine nucleaire. C R Seances Acad Sci III 296(17):815-8, 1983. e-Pub 1983. PMID: 6412990.

      Book Chapters

      1. Gautier J, Aparicio T. DNA Damage Response in Xenopus laevis Cell-Free Extracts. In: Methods Molecular Biology. 2267, 103-144, 2021.
      2. Gautier J, Srinivasan SV. Studies of Cell Cycle Checkpoints using Xenopus cell-free extracts. In: Methods Molecular Biology, 119-158, 2011.
      3. Costanzo V, Robertson K, Gautier J. Xenopus cell-free extracts to study the DNA damage response. In: Methods Mol Biol, 213-27, 2004.
      4. Costanzo V, Gautier J. Xenopus cell-free extracts to study DNA damage checkpoints. In: Methods Mol Biol, 255-67, 2004.
      5. Costanzo V, Gautier J. Single-strand DNA gaps trigger an ATR- and Cdc7-dependent checkpoint. In: Cell Cycle, 17, 2003.
      6. Gautier J. The cdc25 Protein Tyrosine Phosphatase Family. In: Advances in Protein Phosphatases, 151-179, 1993.
      7. Solomon MJ, Gautier J, Lee T, Kirschner MW. Control of p34cdc2 activation. In: Cold Spring Harb Symp Quant Biol, 427-35, 1991.
      8. Gautier J, Beetschen JC. Involvement of the cytoskeleton in early gray crescent formation in axolotl oocyte: relationships with germinal vesicle breakdown. In: Prog Clin Biol Res, 403-6, 1986.
      9. Gautier J, Costanzo V, Greenwood J, Robertson K, Hensey C. Responses to DNA damage in Xenopus: cell death or cell cycle arrest. In: Novartis Foundation Symposium, 221-30.
      10. Gautier J, Hensey C. Developmental regulation of induced and programmed cell death in Xenopus embryos. In: Annals New York Academy Sciences.
      11. Gautier J, Hensey C. Regulation of cell cycle progression following DNA damage. In: Progress in Cell Cycle Research. Springer, 149-162.

      Books (edited and written)

      1. Gautier J, Beetschen JC. A three-step scheme for gray crescent formation in the rotated axolotl oocyte, 1985.

      Web Publications

      1. Aparicio T, Gautier J. More tasks for Dna2 in S-phase, 2012.
      2. Ben-Yehoyada M, Gautier J, Dupre A. The DNA damage response during an unperturbed S-phase, 2007.
      3. Greenwood J, Gautier J. From oogenesis through gastrulation: developmental regulation of apoptosis, 2005.
      4. Yeo W, Gautier J. Early neural cell death: dying to become neurons, 2004.
      5. Shechter D, Costanzo V, Gautier J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates, 2004.
      6. Gautier J, Pal JK, Grossi de Sa MF, Beetschen JC, Scherrer K. Differential cytolocalization of prosomes in axolotl during oogenesis and meiotic maturation, 1988.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 09, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top